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Monkeys serve as important model species for
studying human diseases and developing therapeu-
tic strategies, yet the application of monkeys in
biomedical researches has been significantly hin-
dered by the difficulties in producing animals genet-
ically modified at the desired target sites. Here, we
first applied the CRISPR/Cas9 system, a versatile
tool for editing the genes of different organisms, to
target monkey genomes. By coinjection of Cas9
mRNA and sgRNAs into one-cell-stage embryos,
we successfully achieve precise gene targeting in
cynomolgus monkeys. We also show that this sys-
tem enables simultaneous disruption of two target
genes (Ppar-g and Rag1) in one step, and no off-
target mutagenesis was detected by comprehensive
analysis. Thus, coinjection of one-cell-stage em-
bryos with Cas9 mRNA and sgRNAs is an efficient
and reliable approach for gene-modified cynomol-
gus monkey generation.INTRODUCTION
Monkeys have served as one of the most valuable models for
modeling human diseases and developing therapeutic strategies
due to their close similarities to humans in terms of genetic and
physiological features (Chan, 2013). The genetic modification is
invaluable for generation of monkey models. Although several
transgenic monkeys have been successfully generated using
retroviral or lentiviral vectors (Chan et al., 2001; Niu et al., 2010;836 Cell 156, 836–843, February 13, 2014 ª2014 Elsevier Inc.Sasaki et al., 2009; Yang et al., 2008), precise genomic targeting
in monkeys is the most desired for generating human disease
models and has not been achieved so far (Chan, 2013; Shen,
2013). The recently described clustered regularly interspaced
short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9
system confers targeted gene editing by small RNAs that guide
the Cas9 nuclease to the target site through base pairing (Jinek
et al., 2012). The CRISPR/Cas9 system has been demonstrated
as an easy-handle, highly specific, efficient, and multiplexable
approach for engineering eukaryotic genomes (Mali et al.,
2013a). By now, this system has been successfully used to target
genomic loci in the mammalian cell lines (Cho et al., 2013; Cong
et al., 2013; Mali et al., 2013b;Wang et al., 2013) and several spe-
cies, including mice and rat (Li et al., 2013a; Li et al., 2013b; Ma
et al., 2014; Shen et al., 2013; Wang et al., 2013). But whether
it’s feasible in primates is still unclear.
By taking the advantages of CRISPR/Cas9, we achieved effi-
cient gene targeting in mice and rats by coinjection of one-cell-
stage embryos with Cas9 mRNA and sgRNAs (Li et al., 2013b;
Shen et al., 2013; Ma et al., 2014). Encouraged by our successes
in CRISPR/Cas9-mediated gene targeting, as well as gene
manipulation in early-cleavage-stage embryos of monkeys (Niu
et al., 2010), here, we have extended the application of the
CRISPR/Cas9 system to multiplex genetic engineering in one-
cell-stage embryos of monkeys and successfully obtained
founder animals harboring two gene modifications.
RESULTS AND DISCUSSION
Cas9/RNA Effectively Mediates Gene Disruptions in
Monkey Cell Line
We selected cynomolgus monkey (Macaca fascicularis) as the
model animal because of its body size, availability, similar
menstrual cycle to human, and efficient reproduction ability (Sun
et al., 2008). Three genes, namely Nr0b1 (Nuclear Receptor
Subfamily 0 Group B Member 1), Ppar-g (Peroxisome Prolifera-
tor-Activated Receptor Gamma), andRag1 (Recombination Acti-
vating Gene 1), were selected as the target genes. Two sgRNAs
separated by 117 bp forNr0b1, 2 sgRNAs separated by 49 bp for
Ppar-g, and 1 sgRNA targeting Rag1 (Figure 1A), were designed
as described (Mali et al., 2013b). The efficiency of all sgRNAs
was first tested by cotransfection with Cas9 into the COS-7
cell line derived from African green monkey kidney. Genomic
DNAwas isolated from cells harvested 72 hr after transient trans-
fection and screened for the presence of site-specific gene
modification by PCR amplification of regions surrounding the
target sites as well as T7EN1 cleavage assay (Figure 1B). The
cleavage bands were visible in all target genes. Further charac-
terization of the cleavage by sequencing showed, different indels
were detected at all five target sites with various mutation sizes
(336 +1 bp) at the efficiency of 22.2% for Nr0b1-sgRNA1,
20% for Nr0b1-sgRNA2, 10% for Ppar-g-sgRNA1, 25% for
Ppar-g-sgRNA2, and 23.8% for Rag1-sgRNA (Figure 1C). These
data demonstrated that the selected sgRNAs worked effectively
with Cas9 on monkey genomes.
Cas9/RNA Induces Efficient Genomic Targeting in
Monkey Embryos
Althoughmicroinjection of ZFN or TALENmRNA into embryo has
been successfully used for creation of gene target animals, but
they have not been feasible in monkeys so far (Chan, 2013). To
test whether the CRISPR/Cas9 system works in monkey em-
bryos, the Cas9 (Addgene No. 44758) and sgRNAs were tran-
scribed by T7 RNA polymerase in vitro as described (Shen
et al., 2013). Twenty nanogram/ml Cas9 mRNA and 25 nano-
gram/ml of mixtures containing equal amount of each 5 sgRNAs
were pooled and microinjected into 22 one-cell fertilized eggs of
cynomolgus monkeys. The eggs were further cultured at 37C in
5% CO2. A total of 15 embryos with normal development to
morula or blastocyst stages were collected and examined for
the presence of site-specific genome modification analysis by
PCR, T7EN1 cleavage assay, and sequencing as described
above. The results showed (Figures 2 and S1 available online),
different sgRNAs function by different efficiency. Targetedmodi-
fication with a range of sizes (30 +6 bp) in monkey embryos
occurred at all three target genes with efficiency of 4/15 for
Nr0b1, 7/15 for Ppar-g, and 9/15 for Rag1. Intriguingly, 6 of 15
embryos (embryos 2, 5, 8, 10, 11, and 13) harbored simulta-
neously mutations in both Ppar-g and Rag1; whereas 2 of 15
embryos (embryos 3 and 4) harbored simultaneously mutations
in both Nr0b1 and Rag1, demonstrating that the CRISPR/Cas9
system functions well in monkey embryos.
Cas9/RNA Enables One-Step Multiple Gene
Modifications in Monkeys
With these successes, we set out to generate genetic modified
cynomolgus monkeys. A total of 198MII oocytes were collected.
After fertilization by intracytoplasmic sperm injection (ICSI), Cas9
mRNA and sgRNA mixtures of five sgRNAs were injected as
described above. A total 83 out of 186 injected zygotes were
transferred into 29 surrogate females. Of the recipient mothers,ten pregnancies were established (34.5%; 10 out of 29), one of
which was miscarried 36 days after embryo transfer. Among
the pregnancies, three were twins, three were triplets, and the re-
maining four were single pregnancies (Table 1). So far, a set of
twin female babies (A and B) were successfully delivered at full
term (155 days) by caesarean section (Figure 3A). The other eight
surrogate females are still in the gestation period. The noninva-
sively available tissues of the two infant monkeys, including
placenta, umbilical cord, and ear punch tissues, were collected.
Cas9/RNA-mediated genome modifications were first screened
using genomic DNA from umbilical cord as described above. An
additional band with smaller molecular size was observed by
PCR amplification of the target region of Rag1 in infant B (Fig-
ure 3B), suggesting that the genomic modification occurred in
this founder animal. Next, all the PCR products were subjected
to the T7EN1 cleavage assay (Figure 3C). Cleavage products
were detected in both infants in Rag1 and around the second
sgRNA target site of Ppar-g, indicating the presence of multiple
genomic modifications in the founder monkeys. As expected,
different kinds of indels (one for Ppar-g, four for Rag1) were de-
tected by sequencing of the PCR products (Figure 3D), further
confirming the occurrence of multiple genomic modifications in
the founder monkeys. Of note, no cleavage band was detected
at Nr0b1 (Figure S2), which may be due to the lowest mutation
efficiency of this gene in the embryonic test described above.
The presence of gene modification was further analyzed using
genomic DNA from ear punch tissues and placenta. The same
PCR bands, cleavage bands, and modifications were detected
in Rag1 and Ppar-g genes in both monkeys (Figure 4), further
demonstrating the targeting success and confirming that
CRISPR/Cas9 induces global genome modification in monkey
embryos. Very impressively, no wild-type Rag1 sequence was
detected in the ear punch of founder B (Figure 4C), demon-
strating that the target modification has been ubiquitously and
efficiently integrated into different tissues, most likely including
the germline.
We also further substantiated the allelic targeting effects by
tagging single-nucleotide polymorphisms (SNPs) of parent mon-
keys. A 3.8 kb fragment harboring Rag1-sgRNA target site was
PCR amplified from ear genomic DNA of the parents and
sequenced. Two different combinations of 4 SNPs tagging the
parents derivation were detected downstream of the target site
of Rag1-sgRNA (Figure S3A, Tables S1 and S5). The tagging
SNP combinations of the parents and the founder twins were
further determined by TA cloning and sequencing (Figures S3B
and S3C). The results showed that two tagging SNP combina-
tions segregate in accordance with Mendel’s laws. The Rag1-
sgRNA target site in the ear of founder B showed high target
efficiency was further sequenced. The results (Figure S3D)
showed that both alleles identified by tagging SNPs harbored
target modifications, indicating two alleles from both parents
could bemodified byCas9/RNA-mediated targeting inmonkeys.
Surprisingly, only one genotype with a single-nucleotide inser-
tion for Ppar-g at different tissues of both founder animals was
detected (Figures 3D and 4C). To exclude the possibility that this
single-nucleotide insertion was a SNP rather than a real mutation,
the target sites of theparents andsurrogatemotherwereamplified
to perform T7EN1 cleavage assay and sequencing (Figure S4).Cell 156, 836–843, February 13, 2014 ª2014 Elsevier Inc. 837
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The results excluded the presence of the same single nucleotide,
confirming that the insertion was indeed caused byCRISPR/Cas9
modification to the Ppar-g gene. Taken together, we have suc-
cessfully achieved Cas9/RNA-mediated site-specific modifica-
tions in monkey genome by one-cell embryo microinjection.
Mosaicism
It is worth notifying that the sequence data of both cultured em-
bryos and founder animals showed multiple genotypes (Figures
2B, 3D, and 4C), suggesting the CRISPR/Cas9-mediated cleav-
age had occurred multiple times at different stages of monkey
embryogenesis and resulted in mosaicism of the modification,
as have been observed in other species (Sung et al., 2013; Tes-
son et al., 2011). Currently, the founder babies are housed in
dedicated facilities and developing normally. Due to the limited
access of tissues from the founder infants, more thorough char-
acterization of the genomic modifications as well as phenotype
remains to be performed. This has to be awaited until the founder
monkeys have developed into adulthood. In addition, more full-
term founders will be born and provide more samples for further
assessment of CRISPR/Cas9-mediated genome modification in
monkeys.
Off-Target Analysis
The off-target effect is of a major concern for the CRISPR/Cas9
system (Fu et al., 2013; Hsu et al., 2013; Pattanayak et al., 2013).
We observed CRISPR/Cas9 induced heritable off-target muta-
tion in mice (B.S., W. Zhang, J. Zhang, J. Zhou, J.W., L. Chen,
L. Wang, A. Hodgkins, V. Iyer, X.H., and W.C. Skarnes, unpub-
lished data). To test whether off target occurred in these genetic
modified monkeys, we screened the monkey genome and pre-
dicted a total of 84 potential off-target sites (OTS), including 9
for site 1 of Nr0b1, 20 for site 2 of Nr0b1, 14 for site 1 of Ppar-
g, 20 for site 2 of Ppar-g, and 21 for Rag1, respectively (Table
S2). The off-target effects were comprehensively assessed as
on-target effect analysis using genomic DNA from umbilical
cord. The fragments around all the potential off-target loci
were PCR amplified, then subjected to T7EN1 cleavage assay.
Seventeen PCRproducts yielded cleavage bandswere precisely
examined by TA sequencing. Surprisingly, all the cleavage were
caused by SNP or repeat sequences, and no authentic mutation
was detected (Table S3). These results demonstrated that Cas9/
RNA does not induce detectable off-target mutation in our study.
Considering that the off-target effect is site-dependent, and
more specific strategies using mutated Cas9 have already
been established (Ran et al., 2013), the off-target mutagenesis
can be minimized by optimizing the procedure, suggesting
CRISPR/Cas9 could be a reliable genome target tool for
monkeys.Figure 1. sgRNA:Cas9-Mediated Modifications of Nr0b1, Ppar-g, and R
(A) Schematic diagram of sgRNAs targeting at Nr0b1, Ppar-g, and Rag1 loci. PAM
highlighted in red.
(B) Detection of sgRNA1:Cas9-mediated cleavage ofNr0b1, Ppar-g, and Rag1 by
Con, control.
(C) Sequences of modified Nr0b1, Ppar-g, and Rag1 loci detected in COS-7 cells.
The PAM sequences are underlined and highlighted in green; the targeting seque
indicates positive colonies out of total sequenced.In summary, our current studies demonstrate that site-specific
gene modification can be effectively achieved in monkeys by
coinjection of Cas9 mRNA and sgRNAs into the one-cell
fertilized eggs. We also demonstrate that the multiple genetic
mutations can be established at once without detectable off-
target effects, providing the success of creating genome engi-
neered primates and confirming the CRISPR/Cas9 system is
applicable for monkey genome targeting.
EXPERIMENTAL PROCEDURES
Animals
Healthy female cynomolgus monkeys (Macaca fascicularis), ranging in age
from 5 to 8 years and having body weights of 3.62 to 5.90 kg, were selected
for use in this study. All animals were housed at the Kunming Biomed Interna-
tional (KBI). The KBI is an Association for Assessment and Accreditation of
Laboratory Animal Care accredited facility. All animal protocols are approved
in advance by the Institutional Animal Care and Use Committee of Kunming
Biomed International.
Embryo Collection
Embryo collection and transfer were performed as previously described (Niu
et al., 2010). In brief, 11 healthy female cynomolgus monkeys aged 5–8 years
with regular menstrual cycles were selected as oocyte donors for superovula-
tion, which were performed by intramuscular injection with rhFSH (recombi-
nant human follitropin alfa, GONAL-F, Merck Serono) for 8 days, then rhCG
(recombinant human chorionic gonadotropin alfa, OVIDREL, Merck Serono)
on day 9. Oocytes were collected by laparoscopic follicular aspiration 32–
35 hr after rhCG administration. MII (first polar body present) oocytes were
used to perform intracytoplasmic sperm injection (ICSI) and the fertilization
was confirmed by the presence of two pronuclei.
Cas9/sgRNA Injection of One-Cell Embryos
The zygotes were injected with a mixture of Cas9 mRNA (20 ng/ml) and five
sgRNAs (5 ng/ml each). Microinjections were performed in the cytoplasm of
zygotes using a Nikon microinjection system under standard conditions. The
zygotes then were cultured in the chemically defined, protein-free hamster
embryo culture medium-10 (HECM-10) containing 10% fetal calf serum
(Hyclone Laboratories, SH30088.02) at 37C in 5%CO2. The cleaved embryos
with high quality at two-cell to blastocyst stage were transferred into the
oviduct of the matched recipient monkeys. Twenty-nine monkeys were used
as surrogate recipient, and typically, three embryos were transferred into
each female. The earliest pregnancy diagnosis was performed by ultrasonog-
raphy about 20–30 days after the embryo transfer. Both clinical pregnancy and
number of fetuses were confirmed by fetal cardiac activity and presence of a
yolk sac as detected by ultrasonography (Chen et al., 2012).
DNA Constructs
Codon optimized Cas9 expression construct, Cas9-N-NLS-flag-linker (Addg-
ene No. 44758), was synthesized and inserted into pST1374 vector as
described before (Shen et al., 2013). The pUC57-sgRNA expression vector
used for in vitro transcription of sgRNAs was described as before (Zhou
et al., 2014). pGL3-U6-sgRNA-PGK-Puro vector, containing the U6-PGK-
Puro fragment amplified from pLKO.1 (Addgene No. 8453), sgRNA scaffold
amplified from pUC57-sgRNA, and pGL3-Basic plasmid backbone (Promega,ag1 in COS-7 Cells
sequences are underlined and highlighted in green. sgRNA targeting sites are
PCR and T7EN1 cleavage assay. M, DNAmarker; sg1, sgRNA1; sg2, sgRNA2;
At least 15 TA clones of the PCR products were analyzed by DNA sequencing.
nces in red; the mutations in blue, lower case; deletions (), insertions (+). N/N
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Figure 2. sgRNA:Cas9-Mediated Modifications of Nr0b1, Ppar-g, and Rag1 in Cultured Embryos
(A) Detection of sgRNA1:Cas9-mediated on-target cleavage of Nr0b1, Ppar-g, and Rag1 by T7EN1 cleavage assay. PCR products were amplified and subjected
to T7EN1 cleavage assay. Samples with cleavage bands were marked with an asterisk ‘‘*.’’
(B) DNA sequences of marked samples. TA clones from the PCR products were analyzed by DNA sequencing. Mutations in three PCR products (labeled with red
asterisk) indentified by T7EN1 cleavage assay were not detected by TA sequencing because of limited amount of colonies. The PAM sequences are underlined
and highlighted in green; the targeting sequences in red; the mutations in blue, lower case; deletions (), and insertions (+). N/N indicates positive colonies out of
total sequenced. See also Figure S1.
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Table 1. Summary of Embryo Microinjection of Cas9 mRNA and sgRNAs
MII Oocyte Injected Embryos Embryos for ET Pregnancies /Surrogates Single Pregnancy Multiple Pregnancy Fetuses
198 186 83 34.5% (10/29) 4a 3 twins, 3 triplets 19
aOne miscarried 36 days after embryo transfer.E1751) was used for expression of sgRNAs in cells. Oligos for the generation of
sgRNA expression plasmids (Table S4) were annealed and cloned into the BsaI
sites of pUC57-sgRNA or pGL3-U6-sgRNA-PGK-Puro. pGL3-U6-sgRNA-
PGK-Puro was deposited in Addgene (Addgene NO. 51133).
Cell Culture and Electroporation
COS-7cells (ATCC,CRL-1651)were cultured inDMEM/highglucose (HyClone)
with 10%FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml); 23 106 cells
were electroporated (BioRad Gene Pulser XL) with four micrograms of Cas9
expression plasmids and two micrograms of pGL3-U6-sgRNA-PGK-Puro.
Empty pGL3-U6-sgRNA-PGK-Puro plasmid was used as control. Cells were
collected 72 hr postelectroporation.
In Vitro Transcription
In vitro transcription was performed as described (Zhou et al., 2014). Briefly,
the pST1374-Cas9-N-NLS-flag-linker vector was linearized by Age1 enzyme
and in vitro transcribed using T7 Ultra Kit (Ambion, AM1345). Cas9-N-
NLS-flag-linker mRNA was purified by RNeasy Mini Kit (QIAGEN, 74104).
sgRNA oligos were annealed into pUC57-sgRNA expression vector withFigure 3. sgRNA:Cas9-Mediated Modifications of Ppar-g and Rag1 in
(A) Photographs of 14-day-old founder infants A and B.
(B) PCR products of the target region of Ppar-g and Rag1 in founders. Targeted
genomic DNA of A and B founders. M, DNAmarker; Con, control umbilial cord fro
(C) Detection of sgRNA:Cas9-mediated on-target cleavage of Ppar-g and Rag1
cleavage assay.
(D) Sequences of modified Ppar-g and Rag1 loci detected in founders. At least 18
sequences are underlined and highlighted in green; the targeting sequences in
indicates positive colonies out of total sequenced. See also Figure S2 and S4.T7 promoter. Then expression vectors were linearized by Dra I and tran-
scribed by MEGAshortscript Kit (Ambion, AM1354) in vitro. The sgRNAs
were purified by MEGAclear Kit (Ambion, AM1908) and recovered by alcohol
precipitation.
T7EN1 Cleavage Assay and Sequencing
Different samples, including cells, placenta, umbilical cord, and ear punch tis-
sues, were collected and digested in lysis buffer (10 mM Tris-HCl, 0.4 M NaCl,
2 mMEDTA, 1% SDS, and 100 mg/ml Proteinase K). The genomic DNA was ex-
tracted from lysate by phenol-chloroform recovered by alcohol precipitation.
Genomic DNA from cultured embryos was amplified by REPL1-g Single Cell
Kit (QIAGEN, 150343) according to the manufacturer’s instructions. T7EN1
cleavage assay was performed as described (Shen et al., 2013). In brief, tar-
geted fragments were amplified by PrimerSTAR HS DNA polymerase (Takara,
DR010A) from extracted DNA, and purified with PCR cleanup kit (Axygen, AP-
PCR-50). Purified PCR product was denatured and reannealed in NEBuffer 2
(NEB) using a thermocycler. Hybridized PCR products were digested with
T7EN1 (NEB, M0302L) for 30 min and separated by 2.5% agarose gel. To
detect T7EN cleavage products of Nr0b1 (localized on chromosome X) inFounder Cynomolgus Monkeys
region of Ppar-g and Rag1 loci were PCR amplified from the umbilical cord
m wild-type cynomolgus monkey, which was born 9 days after birth of A and B.
by T7EN1 cleavage assay. PCR products from (B) were subjected to T7EN1
TA clones of the PCR products were analyzed by DNA sequencing. The PAM
red; the mutations in blue, lower case; deletions (), and insertions (+). N/N
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Figure 4. sgRNA:Cas9-Mediated Modifications of Nr0b1, Ppar-g, and Rag1 in Ear and Placenta of Founders
(A) PCR products of the targeted region ofNr0b1, Ppar-g, and Rag1 in founders. Target regions of Nr0b1, Ppar-g, and Rag1 loci were PCR amplified from the ear
and placenta genomic DNA of A and B founders. M, DNA marker; Con, wild-type control.
(B) Detection of sgRNA1:Cas9-mediated on-target cleavage of Nr0b1, Ppar-g, and Rag1 by T7EN1 cleavage assay.
(C) DNA sequences ofNr0b1, Ppar-g, andRag1 loci. The PCR products were analyzed by DNA sequencing. The PAM sequence are underlined and highlighted in
green; the targeting sequences in red; the mutations in blue, lower case; deletions (), and insertions (+). N/N indicates positive colonies out of total sequenced.
See also Figure S3 and S4.cultured embryos, 50 ng of PCR fragment from wild-type control embryos was
mixed with 150 ng of PCR fragments from embryos injected with Cas9 mRNA
and sgRNAs. PCR products with mutations detected by T7EN1 cleavage
assay were sub-cloned into T vector (Takara, D103A). For each sample, col-
onies were picked up randomly and sequenced by M13-47 primer. Primers
for amplifying Nr0b1, Pparg, and Rag1 targeted fragments are listed in
Table S5.
Off-Target Assay
All potential off-target sites with homology to the 23 bp sequence
(sgRNA+PAM) were retrieved by a base-by-base scan of the whole rhesus
genome (BGI CR_1.0/rheMac3), allowing for ungapped alignments with up
to four mismatches in the sgRNA target sequence. In the output of the scan,
potential off-target sites with less than threemismatches in the seed sequence
(1 to 7 base) were selected to PCR amplification using umbilical cord genomic
DNA as templates. The PCR products were first subject to T7EN1 cleavage
assay. The potential off-target sites yielding typical cleavage bands were842 Cell 156, 836–843, February 13, 2014 ª2014 Elsevier Inc.considered as candidates, then the PCR products of the candidates were
cloned and sequenced to confirm the off-target effects. The primers for ampli-
fying the off-target sites are listed in Table S6.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and six tables and can be
found with this article online at http://dx.doi.org/10.1016/j.cell.2014.01.027.
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